dc.identifier.citation |
[1] AG seleci,d.,seleci,m.,walter,j. g.,stahl,f.&scheper,T.2016.NiosomesasNanoparticularDrugCarriers:FundamentalsandRecentA pplications.Journal of Nanomaterials,2016. [2] Aggarwal,r.,cardozo,a.&homer,J.2004.Theassessmentoftopicalnasal drug distribution.Clinical Otolaryngology,29, 201-205. [3] AlyautdinR,KhalinI,NafeezaMI,HaronMH,KuznetsovD.Nanoscaledrugdeliverysystemsandtheblood– brainbarrier.IntJNanomedicine.2014;9:795–811 [4] Appasaheb,p.s.,manohar,s.d.,bhanudas,s.r.&anjaneri,N.2013.Areviewonintranasaldrugdeliverysystem.JournalofAdvancedPharmac y Education&Research Oct-Dec, 3. [5] Arora,p.,sharma,s.&garg,S.2002.Permeabilityissuesinnasaldrugdelivery.Drug discovery today, 7, 967-975. [6] Bagheri,A.,Chu,B.S.andYaakob,H.,2014.Niosomaldrugdeliverysystems:formulation,preparationandapplications.WorldApplSciJ, 32(8),pp.1671-1685. [7] Bakke,h.,samdal,h.,holst,j.,oftung,f.,haugen,i.,kristoffersen,a.c.,haugan,a.,janakova,l.,korsvold,g.&krogh,G.2006Oralsprayimmu nizationmaybeanalternativetointranasalvaccinedeliverytoinducesystemicantibodiesbutnotnasalmucosalorcellularimmunity.Scandi navianjournalofimmunology,63,223-231 [8] Bini,k.,akhilesh,d.,prabhakara,p.&jv,k.2012.Developmentandc h a r a c t e r i z a t i o n ofnonionicsurfactantvesicles(niosomes) fo oraldeliveryoflornoxicam.InternationalJournalofDrugDevelopmentandResearch. [9] Bitter,c.,suter-zimmermann,k.&surber,C.2011.Nasaldrugdeliveryin humans.Topical Applications and the Mucosa.Karger Publishers. [10] Chandu, V.P., Arunachalam, A., Jeganath, S., Yamini, K., Tharangini, K. and Chaitanya, G., 2012. Niosomes: a novel drug delivery system. Int J Novel Trends Pharm Sci, 2(1), pp.25-31. [11] Das,K.andRam,A.,2013.Niosomeasanoveldrugdeliverysystemareview.International Journal AppliedPharmacy,1(6), pp.1-7. [12] Djupesland,P.G.2013.Nasaldrugdeliverydevices:characteristicsandperformanceinaclinicalperspective— areview.Drugdeliveryandtranslational research,3, 42-62. [13] Djupesland,p.g.&skretting,A.2012.Nasaldepositionandclearanceinman:comparisonofabidirectionalpowderdeviceandatraditionalli quidspraypump.Journalofaerosolmedicineandpulmonarydrug delivery,25, 280-289. [14] Djupesland,p.g.,skretting,a.,winderen,m.&holand,T.2004.Bidirectionalnasaldeliveryofaerosolscanpreventlungdeposition.Journal of aerosol medicine, 17, 249-259. [15] Fonseca-Santos, B., Gremião, M.P.D. and Chorilli, M., 2015. Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease. International journal of nanomedicine, 10, p.4981. [16] Gadhiya, P., Shukla, S., Modi, D. and Bharadia, P., 2012. A Review- Niosomes in Targeted Drug Delivery. International Journal for Pharmaceutical Research Scholars, 2, p.61. [17] Gupta,A.,Arora,A.,Menakshi,A.,Sehgal,A.andSehgal,R.,2012.Nanotechnologyand its applications in drugdelivery: areview. [18] Guterres,S.S.,Alves,M.P.andPohlmann,A.R.,2007.Polymericnanoparticles,nanospheres andnanocapsules,for cutaneousapplications.Drugtarget insights, 2, p.147. [19] Hu,C.andRhodes,D.G.,2000.Erratumto‘Proniosomes:ANovelDrugCarrierPreparation’:[Int.J.Pharm.185(1999)23– 35].Internationaljournalofpharmaceutics,206(1), pp.109-122. [20] Kaur,i.p.,bhandari,r.,bhandari,s.&kakkar,V.2008.Potentialofsolidlipidnanoparticlesinbraintargeting.JournalofControlledRelease,1 27, 97-109. [21] Kaur,I.P.,Garg,A.,Singla,A.K.andAggarwal,D.,2004.Vesicularsystemsinoculardrugdelivery:anoverview.Internationaljournalofph armaceutics,269(1),pp.1- [22] Kumar,G.P.andRajeshwarrao,P.,2011.Nonionicsurfactantvesicularsystemsforeffectivedrugdelivery anoverview.ActaPharmaceuti caSinicaB, 1(4),pp.208-219. [23] Mahale, n., thakkar, p., mali, r., walunj, d. &chaudhari, s. 2012. Niosomes: novel sustained release nonionic stable vesicular systems— an overview. Advances in colloid and interface science, 183, 46-54. [24] Mainardes, R.M. and Gremião, M.P.D., 2012. Nanoencapsulation and Characterization of Zidovudine on Poly (L-lactide) and Poly (L-lactide)—Poly (ethylene glycol)-Blend Nanoparticles. Journal of nanoscience and nanotechnology, 12(11), pp.8513-[25] Majgainya, s., soni, s. &bhat, p. novel approach for nose- to-brain drug delivery bypassing blood brain barrier by pressurized olfactory delivery device. [26] Makeshwar, K.B. and Wasankar, S.R., 2013. Niosome: a Novel Drug Delivery System. Asian journal of pharmaceutical research, 3(1), pp.16-20. [27] Management, C. W. O. G. F. A. S. D. 2008. Guideline for Alzheimer's disease management: final report, State of California, Department of Public Health. [28] Manda, R., Suthakaran, R., Kaya, V., Sreedevi, B. and Hurumathfathima, T., 2014. NIOSOME: AN UNIQUE DRUG DELIVERY SYSTEM. [29] McClements, D.J., 2012. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft matter, 8(6), pp.1719-1729. [30] Mehnert, W. and Mäder, K., 2001. Solid lipid nanoparticles: production, characterization and applications. Advanced drug delivery reviews, 47(2), pp.165-196. [31] MOHANRAJ, V. & CHEN, Y. 2006. Nanoparticles-a review. Tropical Journal of Pharmaceutical Research, 5, 561-573. [32] Odeh,F.,AlJaber,H.andKhater,D.,2014.Nanoflorahownanotechnologyenhancedtheuseofactivephytochemicals.ApplicationofNan otechnologyinDrugDelivery, pp.1-15. [33] Pardridge,W.M.2007.Drugtargetingtothebrain.Pharmaceuticalresearch, 24, 1733-1744. [34] Seleci, m., agseleci, d., joncyzk, r., stahl, f., blume, c. &scheper, T. 2016. Smart multifunctional nanoparticles in nanomedicine. BioNanoMaterials, 17, 33-41. [35] Singh, p., prakash, d., ramesh, b., singh, n. &mani, T. T. 2011. Biodegradable polymeric microspheres as drug carriers; A review. Ind J Nov Drug Del, 3, 70-82. [36] Tangri, P. and Khurana, S., 2011. Niosomes: formulation and evaluation. International Journal, 2229, p.7499. [37] Tavano, l., gentile, l., rossi, c. o. &muzzalupo, r. 2013. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery. Colloids and Surfaces B: Biointerfaces, 110, 281-288. [38] Tegeli, v., thorat, y., chougule, g., shivsharan, u., gajeli,g. &kumbhar, S. 2010. Review on concepts and advances in prodrug technology. International Journal of Drug Formulation & Research, 1, 32-57. [39] Tyagi, S., 2012. Novel Drug Delivery System (NDDS): Niosomes. Journal of Biomedical and Pharmaceutical Research, 1(03). [40] Verma, p., thakur, a., deshmukh, k., jha, a. &verma, S. 2010. Routes of drug administration. International Journal of Pharmaceutical Studies and Research, 1, 54-59. [41] Verma, r. k. &garg, s. 2001. Drug delivery technologies and future directions. Pharmaceutical Technology, 25, 1-14. |
en_US |